A single line often inverts meaning once you see what it
answers, so neighbouring messages are always shown.
-
Hello all, Background Thank you again for your assistance in reviewing the Risky Research Review Act. HHS has compiled comments on the bill from throughout HHS to provide them to the Office of Management and Budget (OMB) for consideration. HHS is asking NIH to review the attached document on quick turnaround. The comments included in the document provide high-level concerns across HHS. In particular, we have flagged a comment on the bottom of page 9 with a proposed clarifying edit for your review. Action Item ] ool ] ool OLPA plans to include the nay be asked to review Please let me know if you have any questions. el 6 PM [AID DEA DART NIAID) [E] NIAID) [E] VIH/NIAID) [E] ii a NIH/NIAID) [E] VIH/NIAID) [E] ay >; (NIH/NIAID) [E] I NIH/NIAID) [E] iy NIAID) [E] ) 5 AM [AID DEA DART NIAID) [2] i NIAID) [E] VIH/NIAID) [E] i NIH/NIAID) [E] VIH/NIAID) [] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] Please review the attached draft HHS comments on the Risky Research Review Act and provide your concurrence, or any edits, by COB today, Tuesday July 16th. If you have any concerns with OCGR-Leg's proposed edit to the comment on page 9, please let us know. Please note that NIH OLPA is also working on a separate request from the Senate Health, Education, Labor, and Pensions (HELP) Committee (Chair: Sen. Bernie Sanders, I-VT) for technical assistance on this bill. OLPA plans to include the specific NIAID comments shared yesterday in this separate request. We anticipate we may be asked to review consolidated NIH comments for the HELP Committee this week. Thank you for your ongoing assistance with reviewing this bill. Please let me know if you have any questions. Thanks, Sara
-
Hello all, Background Thank you again for your assistance in reviewing the Risky Research Review Act. HHS has compiled comments on the bill from throughout HHS to provide them to the Office of Management and Budget (OMB) for consideration. HHS is asking NIH to review the attached document on quick turnaround. The comments included in the document provide high-level concerns across HHS. In particular, we have flagged a comment on the bottom of page 9 with a proposed clarifying edit for your review. Action Item Please review the attached draft HHS comments on the Risky Research Review Act and provide your concurrence, or any edits, by COB today, Tuesday July 16th. If you have any concerns with OCGR-Leg's proposed edit to the comment on page 9, please let us know. Please note that NIH OLPA is also working on a separate request from the Senate Health, Education, Labor, and Pensions (HELP) Committee (Chair: Sen. Bernie Sanders, I-VT) for technical assistance on this bill. OLPA plans to include the specific NIAID comments shared yesterday in this separate request. We anticipate we may be asked to review consolidated NIH comments for the HELP Committee this week. Thank you for your ongoing assistance with reviewing this bill. Please let me know if you have any questions. Thanks, Sara
-
Hello all, Background Thank you again for your assistance in reviewing the Risky Research Review Act. HHS has compiled comments on the bill from throughout HHS to provide them to the Office of Management and Budget (OMB) for consideration. HHS is asking NIH to review the attached document on quick turnaround. The comments included in the document provide high-level concerns across HHS. In particular, we have flagged a comment on the bottom of page 9 with a proposed clarifying edit for your review. Action Item Please review the attached draft HHS comments on the Risky Research Review Act and provide your concurrence, or any edits, by COB today, Tuesday July 16th. If you have any concerns with OCGR-Leg's proposed edit to the comment on page 9, please let us know. Please note that NIH OLPA is also working on a separate request from the Senate Health, Education, Labor, and Pensions (HELP) Committee (Chair: Sen. Bernie Sanders, I-VT) for technical assistance on this bill. OLPA plans to include the specific NIAID comments shared yesterday in this separate request. We anticipate we may be asked to review consolidated NIH comments for the HELP Committee this week. Thank you for your ongoing assistance with reviewing this bill. Please let me know if you have any questions. ol ol ay 6 PM AID DEA DART NIAID) [E] 7 NIAID) [E] \IH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [I] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] 1S ) 5 AM [AID DEA DART NIAID) (E] i I NIAID) [E] \IH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [I] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] In the attached revised draft, I jections, I will submit these to NIH Thanks, Sara
-
2024-07-16 12:24
Sara Selgrade
Hello all, Background Thank you again for your assistance in reviewing the Risky Research Review Act. HHS has compiled comments on the bill from throughout HHS to provide them to the Office of Management and Budget (OMB) for consideration. HHS is asking NIH to review the attached document on quick turnaround. The comments included in the document provide high-level concerns across HHS. In particular, we have flagged a comment on the bottom of page 9 with a proposed clarifying edit for your review. Action Item Please review the attached draft HHS comments on the Risky Research Review Act and provide your concurrence, or any edits, by COB today, Tuesday July 16th. If you have any concerns with OCGR-Leg's proposed edit to the comment on page 9, please let us know. Please note that NIH OLPA is also working on a separate request from the Senate Health, Education, Labor, and Pensions (HELP) Committee (Chair: Sen. Bernie Sanders, I-VT) for technical assistance on this bill. OLPA plans to include the specific NIAID comments shared yesterday in this separate request. We anticipate we may be asked to review consolidated NIH comments for the HELP Committee this week. Thank you for your ongoing assistance with reviewing this bill. Please let me know if you have any questions. Thanks, Sara